Filing Flows

Filing Flows › Pelthos Therapeutics (PTHS) › Who owns the stock

Who owns Pelthos Therapeutics (PTHS) stock

23 funds reported Pelthos Therapeutics (PTHS) shares in their latest 13F filings, worth $34.7M in all. The largest holder is Murchinson ($8.6M). Last quarter 16 funds added to their stakes and 5 cut them.

Largest holders of PTHS (13F)Largest holders of PTHS (13F)Murchinson$8.6MIkarian Capital, LLC$7.3MAigh Capital Management LLC$5.4MBoothbay Fund Management, LLC$2.9MVanguard Capital Management LLC$2.7MVanguard Group$2.3MJ. Goldman & Co LP$1.1MDiadema Partners LP$700KWexford Capital LP$632KKnott David M Jr$624K

Largest holders (13F)

FundSharesValueChangeQuarter
Murchinson304,302$8.6Mincrease2026-06-30
Ikarian Capital, LLC256,598$7.3Munchanged2026-06-30
Aigh Capital Management LLC256,012$5.4Mdecrease2026-09-30
Boothbay Fund Management, LLC101,976$2.9Mincrease2026-06-30
Vanguard Capital Management LLC97,134$2.7Mincrease2026-06-30
Vanguard Group75,020$2.3Mincrease2025-12-31
J. Goldman & Co LP38,075$1.1Mdecrease2026-06-30
Diadema Partners LP24,773$700Kunchanged2026-06-30
Wexford Capital LP22,364$632Knew2026-06-30
Knott David M Jr22,073$624Kincrease2026-06-30
Citadel Advisors LLC15,046$425Knew2026-06-30
Geode Capital Management, LLC14,650$414Kdecrease2026-06-30
Pale Fire Capital SE12,919$365Kunchanged2026-06-30
1492 Capital Management LLC10,380$293Knew2026-06-30
Vanguard Fiduciary Trust9,873$279Kincrease2026-06-30

Pelthos Therapeutics' latest quarter

Pelthos Therapeutics, Q2 2026: revenue $15.6M, operating margin -111.0%, net loss $23.4M, operating cash flow −$7.7M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most PTHS stock?

By the latest 13F filings: Murchinson ($8.6M); Ikarian Capital, LLC ($7.3M); Aigh Capital Management LLC ($5.4M); Boothbay Fund Management, LLC ($2.9M); Vanguard Capital Management LLC ($2.7M).

What is the short interest in PTHS?

142,250 shares were sold short at the 2026-10-15 settlement, 36.03% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.